Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice

Behavioural Brain Research

Volumn 294, Issue , 2015, Pages 7-16

  Fowler, Stephen C ^a   Muma, Nancy A ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

CAG140 knock in mouse; Distance traveled; Force plate; Gait; Huntington's disease; Power spectra

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BODY WEIGHT; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FORCE PLATE ACTOMETER; GAIT DISORDER; HUNTINGTON CHOREA; LOCOMOTION; LONGITUDINAL STUDY; MALE; MEDICAL DEVICE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; POWER SPECTRUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REACTION TIME; ACCELEROMETRY; ANIMAL; BIOMECHANICS; C57BL MOUSE; DEVICES; DISEASE COURSE; DISEASE MODEL; GAIT; GENE TARGETING; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TRANSGENIC MOUSE; TREMOR;

ACCELEROMETRY; ANIMALS; BEHAVIOR, ANIMAL; BIOMECHANICAL PHENOMENA; BODY WEIGHT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GAIT; GENE KNOCK-IN TECHNIQUES; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; TREMOR;

EID: 84938862171     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.07.036     Document Type: Article

References (32)

1. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72(6):971-983. (PMID 8,458,085).
2. Menalled L., Lutz C., Ramboz S., Brunner D., Lager B., Noble S., Park L., Howland D. A Field Guide to Working with Mouse Models of Huntington's Disease 2014, arxiv:/Chdifoundation.org.
3. Menalled L.B., Kudwa A.E., Miller S., Fitzpatrick J., Watson-Johnson J., Keating N., Ruiz M., Mushlin R., Alosio W., McConnell K., Connor D., Murphy C., Oakeshott S., Kwan M., Beltran J., Ghavami A., Brunner D., Park L.C., Ramboz S., Howland D. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175. PLoS One 2012, 7(12):6e49838. (PMID 23,284,626).
4. Fowler S.C., Birkestrand B.R., Chen R., Moss S., Vorontsova E., Wang G., Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods 2001, 107(1-2):107-124. (PMID 11,389,948).
5. Fowler S.C., Miller B.R., Gaither T.W., Johnson M.A., Rebec G.V. Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease. Behav. Brain Res. 2009, 202(1):130-137. (PMID 19,447,289).
6. Dai Y., Dudek N.L., Li Q., Fowler S.C., Muma N.A. Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease. J. Neurosci. 2009, 29(37):11550-11559. (PMID 19,759,302).
7. Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., Chesselet M.F. Extensive early motor, non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157(1):280-295. (PMID 18,805,465).
8. Hickey M.A., Zhu C., Medvedeva V., Lerner R.P., Patassini S., Franich N.R., Maiti P., Frautschy S.A., Zeitlin S., Levine M.S., Chesselet M.F. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease. Mol. Neurodegener. 2012, 7(12):1-16. (PMID 22,475,209).
9. Hickey M.A., Zhu C., Medvedeva V., Franich N.R., Levine M.S., Chesselet M.F. Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease. Mol Cell Neurosci. 2012, 49(2):149-157. (PMID 22,044,764).
10. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., Chesselet M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140CAG repeats. J. Comp. Neurol. 2003, 465(1):11-26. (PMID 12,926,013).
11. Deng Y.P., Wong T., Wan J.Y., Reiner A. Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease. Front. Syst. Neurosci. 2014, 8(198). (PMID 25,360,089).
12. Rising A.C., Xu J., Carlson A., Napoli V.V., Denovan-Wright E.M., Mandel R.J. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140CAG repeats. Exp. Neurol. 2011, 228(2):173-182. (PMID 21,192,926).
13. Deng Y.P., Wong T., Bricker-Anthony C., Deng B., Reiner A. Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice. Neurobiol. Dis. 2013, 60:89-107. (PMID 23,969,239).
14. Murphy-Nakhnikian A., Dorner J.L., Fischer B.I., Bower-Bir N.D., Rebec G.V. Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140CAG Huntington's disease mice. Neurosci. Lett. 2012, 512(1):1-5. (PMID 22,327,034).
15. Cummings D.M., Cepeda C., Levine M.S. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease. ASN Neuro. 2010, 2(3):e00036. (PMID 20,585,470).
16. Stanford J.A., Shuler J.M., Fowler S.C., Stanford K.G., Ma D., Bittel D.C., Le Pichon J.B., Shapiro S.M. Hyperactivity in the Gunn rat model of neonatal jaundice: age-related attenuation and emergence of gait deficits. Pediatr. Res. 2015, 77(3):434-439. (PMID 25,518,009) [Epub ahead of print].
17. Fowler S.C., Zarcone T.J., Vorontsova E., Chen R. Motor and associative deficits in D2 dopamine receptor knockout mice. Int. J. Dev. Neurosci. 2002, 20(3-5):309-321. (PMID 12,175,868).
18. Fresiello A., Grammatikopoulos G., Pignatelli M., Sadile A.G. Environmental factors during postnatal period modify activity and non-selective attention in the naples high-excitability rat. Behav. Brain Res. 2002, 130(1-2):111-115. (PMID 11,864,726).
19. Koller W.C., Trimble J. The gait abnormality of Huntington's disease. Neurology 1985, 35(10):1450-1454. (PMID 3,162,109).
20. Menalled L., El-Khodor B.F., Patry M., Suárez-Fariñas M., Orenstein S.J., Zahasky B., Leahy C., Wheeler V., Yang X.W., MacDonald M., Morton A.J., Bates G., Leeds J., Park L., Howland D., Signer E., Tobin A., Brunner D. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol. Dis. 2009, 35(3):319-336. (PMID 19,464,370).
21. Delval A., Krystkowiak P., Blatt J.L., Labyt E., Dujardin K., Destée A., Derambure P., Defebvre L. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study. J. Neurol. 2006, 253(1):73-80. (PMID 16,096,818).
22. Walker F.O. Huntington's disease. Lancet 2007, 369(9557):218-228. (PMID 17,240,289).
23. Ross C.A., Aylward E.H., Wild E.J., Langbehn D.R., Long J.D., Warner J.H., Scahill R.I., Leavitt B.R., Stout J.C., Paulsen J.S., Reilmann R., Unschuld P.G., Wexler A., Margolis R.L., Tabrizi S.J. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 2014, 10(4):204-216. (PMID 24,614,516).
24. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999, 19(8):3248-3257. (PMID 10,191,337).
25. Pallier P.N., Drew C.J., Morton A.J. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res. Bull. 2009, 78(6):347-355. (PMID 19,010,400).
26. Thompson J.C., Harris J., Sollom A.C., Stopford C.L., Howard E., Snowden J.S., Craufurd D. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J. Neuropsychiatry Clin. Neurosci. 2012, 24(1):53-60. (PMID 22,450,614).
27. van Praag H., Kempermann G., Gage F.H. Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 2000, 1(3):191-198. (PMID 11,257,907).
28. van Dellen A., Blakemore C., Deacon R., York D., Hannan A.J. Delaying the onset of Huntington's in mice. Nature 2000, 404(6779):721-722. (PMID 10,783,874).
29. Mazarakis N.K., Mo C., Renoir T., van Dellen A., Deacon R., Blakemore C., Hannan A.J. Super-enrichment' reveals dose-dependent therapeutic effects of environmental stimulation in a transgenic mouse model of huntington's disease. J. Huntingtons Dis. 2014, 3(3):299-309. (PMID 25,300,333).
30. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995, 377(6548):424-428. (PMID 175,667,566,118).
31. Heng M.Y., Detloff P.J., Albin R.L. Rodent genetic models of Huntington disease. Neurobiol. Dis. 2008, 2(1):1-9. (PMID 18,638,556).
32. Ferrante R.J. Mouse models of Huntington's disease methodological considerations for therapeutic trials. Biochim. Biophys. Acta 2009, 92(6):506-520. (PMID 19,362,590).